iNtRON Biotechnology Market Cap

iNtRON Biotechnology has a market cap or net worth of 135.94 billion as of April 24, 2025. Its market cap has decreased by -47.08% in one year.

Market Cap

135.94B

Enterprise Value

87.41B

Revenue

6.42B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,195.00

Market Cap Chart

Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 135.94B, an increase of 42.65%. That is a compound annual growth rate of 2.52%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	135.94B	-25.94%
Dec 30, 2024	183.56B	-37.01%
Dec 28, 2023	291.42B	7.98%
Dec 29, 2022	269.88B	-61.99%
Dec 30, 2021	710.00B	-22.41%
Dec 30, 2020	915.06B	97.15%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	75.87T
Celltrion	33.69T
ALTEOGEN	20.73T
Yuhan	8,653.14B
SK Biopharmaceuticals	8,152.41B
HLB Co., Ltd.	7,332.20B
Peptron	4,142.27B
LigaChem Biosciences	4,078.10B

Market Cap Rankings